ArticleCell transplantation2018

Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.

Serdar Kabataş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.